Pfizer Ventures led the Series B financing of Cartography Biosciences, whose lead program addresses a promising target for colorectal cancer. The startup’s drugs come from platform technologies that analyze data from healthy cells and cancer cells to identify cancer-specific targets. The post Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic…
Before policymakers, employers, insurers, or taxpayers commit ever-larger sums to the system, an uncomfortable question deserves attention: How much additional capacity does healthcare actually need and what measurable outcomes should society expect in return? The post Healthcare’s Most Avoided Question: “How Much Exactly Do You Need, and What Will America Get in Return?” appeared first…
This interactive tracks announced insurer exits from and entries into the ACA Marketplaces for 2027.
For decades, the United States has held considerable power in determining the direction of global health policies and programs. President Donald Trump issued three executive orders on his first day in office that may signal the end of that era, health policy experts said. Trump’s order to withdraw from the World Health Organization means the…
The Medicare Part D program provides an outpatient prescription drug benefit to 56 million older adults and people with long-term disabilities in Medicare who enroll in private plans. This brief analyzes Medicare Part D enrollment, premiums, and cost sharing in 2026 and trends over time, based on data from the Centers for Medicare & Medicaid…
Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. The post ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood…
The promise of automation in RCM is undeniable, but achieving it requires more than simply adopting new tools. Hospitals must take deliberate steps to prepare their people, processes, and systems for change. The post 5 Tips for How Hospitals Should Prepare for RCM Automation appeared first on MedCity News.
In this episode, Dr. Ziad Obermeyer joins Chip to talk about AI bias in patient management, including how far the health care industry has come since his groundbreaking research that revealed alarming biases in a widely used algorithm that underestimated the health needs of Black patients.
Pieces Technologies’ conversational AI tool allows cancer patients to ask questions about their care, while simultaneously ascertaining information about social determinants of health
As Congress weighs potential cuts in federal Medicaid spending through budget reconciliation, one option under consideration is to limit the use of state taxes on providers. This brief uses data from KFF’s 2024-2025 survey of Medicaid directors to describe states’ current provider taxes and the federal rules governing them.